Cancer Immunology, Immunotherapy Issues Research Articles in February 2022 Edition
January 24, 2022
January 24, 2022
BASEL, Switzerland, Jan. 24 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles, including the following topics, in its February 2022 edition:
Original Articles:
* Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma
* Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients wi . . .
Original Articles:
* Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma
* Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients wi . . .